Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 5Sleep Wake Disorders 1Sleep Disorders, Circadian Rhythm 1Radiodermatitis 1Radiation Injuries 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pain 1Neoplasms 1Neoplasm Metastasis 1Melanoma 1Keratosis, Actinic 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Depression 1Delirium 1Brain Neoplasms 1Brain Concussion 1

Interventions

Temozolomide 73Bevacizumab 57Radiotherapy 40Radiosurgery 28Carboplatin 23Nivolumab 17Etoposide 17Cisplatin 17pembrolizumab 16Irinotecan 16Ipilimumab 15Magnetic Resonance Spectroscopy 14Erlotinib Hydrochloride 14Cyclophosphamide 14Carmustine 14Pemetrexed 13Topotecan 10Surgical Procedures, Operative 10Capecitabine 10Lapatinib 9Filgrastim 9Trastuzumab 8Thalidomide 8Sunitinib 8Paclitaxel 8Lomustine 8Aminolevulinic Acid 8encorafenib 7binimetinib 7Vincristine 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Brain Neoplasms × Melatonin × Clear all
NCT00031967 2020-10-22

Melatonin and Radiation Therapy in Treating Patients With Brain Metastases

Radiation Therapy Oncology Group

Phase 2 Completed
CNS

Brain Neoplasms, Neoplasm Metastasis, Radiation Injuries

Data powered by HemOnc (CC BY 4.0) Colophon âš¡